Latest Breaking News On - சிங்கப்பூர் புற்றுநோய் பதிவு - Page 2 : vimarsana.com

 E-Mail IMAGE: Quantitative MR images of the liver from six patients presenting with liver cancer produced by Perspectum s LiverMultiScan which will be used in a new study led by National Cancer Centre. view more  Credit: Mole DJ et al. Plos One. 2020;15(12):e0238568 Singapore, 3 May 2021 - A first of its kind cohort study on patients at high risk of developing primary liver cancer also known as hepatocellular carcinoma (HCC), has been launched to diagnose HCC more accurately at an earlier stage and to predict an individual s likelihood of developing the cancer. HCC is the sixth most common cancer in the world but the third most common cause of cancer deaths globally.[1] In Singapore, HCC is the third and fourth most common cause of cancer deaths, amongst males and females respectively.[2] While potentially curative treatment is possible with early diagnosis, only 20% of HCC cases are detected at a stage where cure is possible. This investigator-initiated multi-centre s

National university hospitalSingapore generalMarine paradeTan tock seng hospitalBukit merahMihir gandhiAsia pacificWang yulanDan yock youngJason chang pikCentre for quantitative medicineNational registry of diseases officeDivision of gastroenterologyAgency of scienceLee kong chian school of medicineNational cancer centre of singapore